Alqassem Abuarqoub

Alqassem Abuarqoub currently serves as a Scientist II at FogPharma, focusing on the design of cellular pharmacology assays utilizing advanced techniques for drug discovery and development since January 2024. Prior to this role, Alqassem worked as a Scientist at Ribon Therapeutics from September 2022 to December 2023. Education includes a PhD in Cellular, Molecular and Biomedical Sciences from the University of Vermont, a Master's in Biotechnology from Georgetown University, and a Bachelor's in Biotechnology and Genetic Engineering from Philadelphia University. Previous experience encompasses a blend of research and teaching roles, including significant projects at the University of Vermont and research assistant positions at the Georgetown Lombardi Comprehensive Cancer Center. Additionally, Alqassem has technical expertise in laboratory techniques and has contributed to marketing and technical sales in the biotech industry.